Trump’s plans to lower drug prices have echoes of past efforts

Taking stock of the drug industry, from the lab to the medicine chest

April 16, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

ROBERTO SCHMIDT/AFP via Getty Images STAT+ | Trump's plans to lower drug prices have echoes of past efforts New health care initiative contains items already struck down by courts, and a 'pill penalty' move designed to lower prices will raise them, critics say. By John Wilkerson STAT+ | Opinion: Promising signs for stem cell-based therapies for Parkinson's in two new studies Larger trials of allogeneic cells for Parkinson's disease with more participants and additional features like blinding and placebo controls are crucial. By Paul Knoepfler Vaccine advisory panel, a frequent target of Kennedy, meets with little drama  An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it. By Jason Mast Andrew Harnik/Getty Images RFK Jr. plans changes to vaccine injury reporting system Critiques of the vaccine injury reporting system have long been part of Kennedy's efforts to questions the safety of immunizations. By Daniel Payne

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser